2024

• Simmonds, Lucy; Jamtøy, Kent Are; Aschehoug, Irina; Hara, Sozaburo; Meisingset, Tore Wergeland; Matharu, Manjit S.. (2024) Open label experience of repeated OnabotulinumtoxinA injections towards the sphenopalatine ganglion in patients with chronic cluster headache and chronic migraine. Cephalalgia
  Academic article

2021

• Jamtøy, Kent Are; Tronvik, Erling Andreas; Bratbak, Daniel Fossum; Crespi, Joan Vidal; Stovner, Lars Jacob; Aschehoug, Irina. (2021) OnabotulinumtoxinA injection towards the SPG for treating symptoms of refractory chronic rhinosinusitis with nasal polyposis: a pilot study. Acta Oto-Laryngologica
  Academic literature review

2018

• Aschehoug, Irina; Bratbak, Daniel Fossum; Tronvik, Erling Andreas. (2018) Long-term outcome of patients with intractable chronic cluster headache treated with injection of onabotulinum toxin A toward the sphenopalatine ganglion - an observational study. Headache
  Academic article
• Crespi, Joan Vidal; Bratbak, Daniel Fossum; Dodick, David W.; Matharu, Manjit; Jamtøy, Kent Are; Aschehoug, Irina. (2018) Measurement and implications of the distance between the sphenopalatine ganglion and nasal mucosa: a neuroimaging study. The Journal of Headache and Pain
  Academic article

2017

• Martins, Catia; Aschehoug, Irina; Ludviksen, Marit Krey; Holst, Jens; Finlayson, Graham; Wisløff, Ulrik. (2017) High-intensity interval training, appetite, and reward value of food in the obese. Medicine & Science in Sports & Exercise
  Academic article

2016

• Martins, Catia; Aschehoug, Irina; Ludviksen, Marit Krey; Mehus, Ingar; Wisløff, Ulrik; Kulseng, Bård Eirik. (2016) High-intensity interval training and isocaloric moderate-intensity continuous training results in similar improvements in body composition and fitness in obese individuals. International Journal of Sport Nutrition & Exercise Metabolism
  Academic article
• Bratbak, Daniel Fossum; Nordgård, Ståle; Stovner, Lars Jacob; Linde, Mattias; Dodick, David W.; Aschehoug, Irina. (2016) Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic migraine. Cephalalgia
  Academic article